China Reinsurance (Group) (1508) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Sep, 2026Executive summary
Unaudited financial data for the nine months ended 30 September 2025 were disclosed, prepared under PRC Accounting Standards for Business Enterprises.
The report covers China Re Life, a subsidiary, following the issuance of RMB5.0 billion in capital supplementary bonds.
Financial highlights
Total assets reached RMB321.0 billion as of 30 September 2025.
Total liabilities stood at RMB294.8 billion, with owners' equity at RMB26.2 billion.
Net profit for the nine-month period was RMB2.95 billion.
Total comprehensive income amounted to RMB3.99 billion.
Gross written premium was RMB49.53 billion, with premiums earned at RMB42.51 billion.
Outlook and guidance
Quarterly solvency statements and financial reports will continue to be disclosed as required by bond issuance regulations.
Latest events from China Reinsurance (Group)
- Net profit attributable to equity holders surged 184.6% on 6.8% higher insurance revenue.1508
Q2 2024 - Net profit reached RMB979.94 million on RMB285.38 billion in assets for the nine months ended 30 September 2024.1508
Q3 2024 - Net profit surged 86.8% year-on-year, with record premiums and strong investment returns.1508
Q4 2024 - Q1 2025 net profit was RMB620.87 million on RMB9.98 billion operating income.1508
Q1 2025 - Record profits, premiums, and dividends in 2025, with strong digital and global expansion.1508
Q4 2025 - Net profit up 15.1% to RMB7,596 million, driven by growth in life and health reinsurance.1508
Q2 2026 - Q1 2026 net profit reached RMB336.9 million on assets of RMB94.1 billion.1508
Q1 2026 - Net profit up 11.4% to RMB 6,599m, with robust solvency and mixed segment performance.1508
Q2 2025